UC News

Cincinnati Epilepsy Center Again Designated Level 4

headshot of Administrator By Administrator
2 minute read April 8, 2015

The Epilepsy Center at the UC Neuroscience Institute has again been designated a Level 4 Epilepsy Center—the highest level—by the National Association of Epilepsy Centers (NAEC). The center, directed by Michael Privitera, MD, a professor in the UC College of Medicine’s Department of Neurology and Rehabilitation Medicine, has held this designation consistently since 2005.

The NAEC is a nonprofit trade association with a membership of more than 170 epilepsy centers. The organization defines Level 4 epilepsy centers as "having the professional expertise and facilities to provide the highest level medical and surgical evaluation and treatment of patients with complex epilepsy.” The designation of Level 4 or the NAEC’s other level, Level 3, is made as a result of member centers’ responses to a self-designation survey.

"The Level 4 designation is only one indicator of our center's excellence," says David Ficker, MD, an associate professor in the Department of Neurology and Rehabilitation Medicine and medical director of the Epilepsy Monitoring Unit at UC Medical Center. "From expertise in the outpatient clinic to advanced epilepsy diagnostic testing and surgical treatment, our Epilepsy Center provides outstanding care for patients with epilepsy and seizures. No patient with epilepsy needs to leave the region to get expert care for their seizures.

The UC Neuroscience Institute is one of four institutes of the UC College of Medicine and UC Health. It includes 14 centers and programs.

Tags

Related Stories

1

Certain weather patterns can trigger migraines

June 8, 2026

Certain weather patterns really do trigger migraine headaches — and the incidence is more common in the Midwest. As WGN 9 in Chicago recently reported, researchers at the University of Cincinnati College of Medicine have identified two specific weather patterns associated with an increased risk of headaches.

3

At least two weather patterns increase headaches, UC study suggests

June 4, 2026

University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.